Based on the dynamic regulatory network of liver regeneration and lactylation modification, this study successfully identified six core genes, namely Ccna2, Csrp2, Ilf2, Kif2c, Racgap1, and Vars, as potential therapeutic targets and biological biomarkers for HCC. This evidence concerns the gene RACGAP1 and hepatocellular carcinoma.